Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 3, 2011PLoS ONEOpen Access

A Phase IIA Randomized Clinical Trial of a Multiclade HIV-1 DNA Prime Followed by a Multiclade rAd5 HIV-1 Vaccine Boost in Healthy Adults (HVTN204)

View Full Paper
Ask AI
Bookmark
Share

Authors

GCGavin ChurchyardUniversity of the WitwatersrandCMCecilia MorganFred Hutch Cancer CenterEAElizabeth M. AdamsAstraZeneca (Brazil)

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Churchyard et al. (2011) studied this question.

synapsesocial.com/papers/6a8506e2abaf849ca59df08fhttps://doi.org/10.1371/journal.pone.0021225
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Safety and Immunogenicity Study of Multiclade HIV-1 Adenoviral Vector Vaccine Alone or as Boost following a Multiclade HIV-1 DNA Vaccine in Africa2010 · 119 citations
  2. 2Recommendations for the Design and Use of Standard Virus Panels To Assess Neutralizing Antibody Responses Elicited by Candidate Human Immunodeficiency Virus Type 1 Vaccines2005 · 240 citations
  3. 3Response definition criteria for ELISPOT assays revisited2010 · 231 citations
  4. 4Initial B-Cell Responses to Transmitted Human Immunodeficiency Virus Type 1: Virion-Binding Immunoglobulin M (IgM) and IgG Antibodies Followed by Plasma Anti-gp41 Antibodies with Ineffective Control of Initial Viremia2008 · 643 citations
  5. 5Multiclade Human Immunodeficiency Virus Type 1 Envelope Immunogens Elicit Broad Cellular and Humoral Immunity in Rhesus Monkeys2005 · 132 citations